Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 362 followers
Latest posts
Last updated 1 day ago
Summit stock crashes as Akeso shares bispecific's first overall survival data in Keytruda head-to-head trial
1 day ago
Akeso has shared for the first time overall survival data from a...
With industry's onshoring tide rolling on, Amgen blueprints $900M expansion at Ohio biomanufacturing plant
1 day ago
Amgen is plugging $900 million into an expansion of its biomanufacturing facility...
Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years
2 days ago
AbbVie aims to invest $10 billion in the U.S. through 2035 to...
Gilead, not sweating looming tariff threats, stands by long-acting PrEP launch
2 days ago
As potential HIV policy changes, looming tariffs and sweeping cuts across federal...
Akeso, Sino Biopharm’s Anniko enters crowded PD-1 market with FDA approval in head and neck cancer subtype
2 days ago
Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso...
US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide
2 days ago
Makers of knockoff in-demand weight loss drugs are fast running out of...
Angus on Angus: A Fierce oncology discussion
2 days ago
Two journalists, one name and a candid conversation—Angus Liu and Angus Chen...
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
2 days ago
AstraZeneca and Daiichi Sankyo are gunning to get oncology med Enhertu a...
Merck KGaA confirms late-stage talks with SpringWorks about $3.5B buyout
2 days ago
Merck KGaA’s protracted pursuit of SpringWorks Therapeutics may be nearing its endgame...
Thermo Fisher jumps on the US investment bandwagon with $2B in additional spending
3 days ago
Thermo Fisher has joined the life science investment splurge in the U.S...
Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through
3 days ago
Halozyme is not holding back against Merck & Co. in their injectable...
UCB partners with Dr. Pimple Popper in ongoing hidradenitis suppurativa campaign
3 days ago
Like several other biopharmas before it, UCB has turned to perhaps the...